Bio-Rad Laboratories Inc (NYSE:BIO)
$ 330.53 2.17 (0.66%) Market Cap: 9.23 Bil Enterprise Value: 9.00 Bil PE Ratio: 0 PB Ratio: 1.24 GF Score: 78/100

Q3 2023 Bio Rad Laboratories Inc Earnings Call Transcript

Oct 26, 2023 / 09:00PM GMT
Release Date Price: $291.53 (+0.50%)
Operator

Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the Bio-Rad Third Quarter 2023 Financial Results Conference Call and Webcast. (Operator Instructions). And please be advised that today's call is being recorded on Thursday, October 26, 2023.

I would now like to turn the conference over to Edward Chung. Head of Investor Relations. Please go ahead.

Yong Chung
Bio-Rad Laboratories, Inc. - VP of IR

Good afternoon, everyone. Thank you for joining us. Today, we will review the third quarter 2023 financial results and provide an update on key business trends for Bio-Rad.

With me on the call today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Simon May, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.

Before we begin our review, I'd like to caution everyone that we will be making forward-looking statements about management's goals,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot